Gloucester Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Gloucester Pharmaceuticals Ownership

Who owns Gloucester Pharmaceuticals?

Gloucester Pharmaceuticals is owned by Celgene. It was acquired on December 7, 2009.

Gloucester Pharmaceuticals Business Overview

Where is Gloucester Pharmaceuticals headquartered?

Gloucester Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What sector is Gloucester Pharmaceuticals in?

Gloucester Pharmaceuticals is a life science company.

When was Gloucester Pharmaceuticals founded?

Gloucester Pharmaceuticals was founded in 2002.

Life Science M&A Summary in 2009

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

Gloucester Pharmaceuticals, Inc.

One Broadway 14th Floor,
Cambridge, Massachusetts 02142
United States,
(617) 583-1300

Gloucester develops cancer therapies including Istodax, which was approved by the Food and Drug Administration last month for treatment of cutaneous T-cell lymphoma patients who have had a least one prior systemic therapy. The treatment also has orphan drug designation for treatment of non-Hodgkin's T-cell lymphomas including CTCL and peripheral T-cell lymphoma, as well as fast-track status for PTCL.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.